NCT05942365View on ClinicalTrials.gov

A Drug Interaction Study Assess the Effects of ZSP1273 Tablets on the Pharmacokinetics of Warfarin and Midazolam

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 25, 2023

Primary Completion Date

July 21, 2023

Study Completion Date

August 4, 2023

Conditions

Drug Drug InteractionWarfarinMidazolam

Interventions

DRUG

ZSP1273

Drug Warfarin oral Drug midazolam oral

Trial Locations (1)

Unknown

the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou

All Listed Sponsors

lead

Guangdong Raynovent Biotech Co., Ltd

INDUSTRY

NCT05942365 - A Drug Interaction Study Assess the Effects of ZSP1273 Tablets on the Pharmacokinetics of Warfarin and Midazolam | Biotech Hunter | Biotech Hunter